Literature DB >> 12768606

Surveillance of respiratory diseases among construction and trade workers at Department of Energy nuclear sites.

John M Dement1, Laura Welch, Eula Bingham, Buck Cameron, Carol Rice, Patricia Quinn, Knut Ringen.   

Abstract

BACKGROUND: Medical screening programs were begun in 1996 and 1997 at three Department of Energy (DOE) nuclear weapons facilities (Hanford Nuclear Reservation, Oak Ridge, and the Savannah River Site) to evaluate whether current and former construction workers are at significant risk for occupational illnesses. The focus of this report is pneumoconiosis associated with exposures to asbestos and silica among workers enrolled in the screening programs through September 30, 2001.
METHODS: Workers provided a detailed work and exposure history and underwent a respiratory examination, which included a respiratory history and symptom questionnaire, a posterior-anterior (P-A) chest radiograph, and spirometry. Both stratified and multivariate logistic regression analyses were used to explore the risk of disease by duration of DOE employment and frequency of exposure, while controlling for potential confounders such as age, race, sex, and other work in the construction and building trades.
RESULTS: Of the 2602 workers, 25.2% showed one or more chest X-ray changes by ILO criteria and 42.7% demonstrated one or more pulmonary function defects. The overall prevalence of parenchymal changes by ILO criteria (profusion 1/0 or greater) was 5.4%. In the logistic regression models, the odds ratio for parenchymal disease was 2.6 (95% confidence interval (CI) = 1.0-6.6) for workers employed 6 to 20 years at Hanford or Savannah River and increased to 3.6 (95% CI = 1.1-11.6) for workers employed more than 35 years, with additional incremental risks for workers reporting routine exposures to asbestos or silica.
CONCLUSIONS: Continued surveillance of workers is important given their increased risk of disease progression and their risk for asbestos related malignancies. Smoking cessation programs should also be high priority and continued abstinence for former smokers reinforced. Although the observed respiratory disease patterns are largely reflective of past exposures, these findings suggest that DOE needs to continue to review industrial hygiene control programs for work tasks involving maintenance, repair, renovation, and demolition. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768606     DOI: 10.1002/ajim.10226

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  5 in total

1.  Evaluation and comparison of three exposure assessment techniques.

Authors:  R L Neitzel; W E Daniell; L Sheppard; H W Davies; N S Seixas
Journal:  J Occup Environ Hyg       Date:  2011-05       Impact factor: 2.155

2.  Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province.

Authors:  Magdalena Rosell-Murphy; Rafael Abós-Herràndiz; Josep Tarrés; Xavier Martínez-Artés; Isabel García-Allas; Ilona Krier; Gloria Cantarell; Miguel Gallego; Ramon Orriols; Constança Albertí
Journal:  BMC Public Health       Date:  2010-04-22       Impact factor: 3.295

3.  Exploration of work and health disparities among black women employed in poultry processing in the rural south.

Authors:  Hester J Lipscomb; Robin Argue; Mary Anne McDonald; John M Dement; Carol A Epling; Tamara James; Steve Wing; Dana Loomis
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

4.  A case-control study of airways obstruction among construction workers.

Authors:  John Dement; Laura Welch; Knut Ringen; Patricia Quinn; Anna Chen; Scott Haas
Journal:  Am J Ind Med       Date:  2015-06-29       Impact factor: 2.214

5.  Risk Evaluation of Construction Workers' Exposure to Silica Dust and the Possible Lung Function Impairments.

Authors:  Elahe Tavakol; Mansour Azari; Rezvan Zendehdel; Sousan Salehpour; Soheila Khodakrim; Saeed Nikoo; Behzad Saranjam
Journal:  Tanaffos       Date:  2017-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.